Wegovy 1 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FFAFK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,107
Award facts
- Contract value 100% obligated
- $38,107.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Wegovy 1 mg/0.5 ml pen injections valued at $38,107.05. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The product will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility, with completion scheduled for September 5, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, and serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards with the Defense Logistics Agency covering diverse therapeutic domains, including specialty medications, vaccines, and medical devices. All reviewed contract awards demonstrate AmerisourceBergen's capability to meet federal procurement requirements through open competition, with delivery orders featuring firm fixed pricing ranging from minimal to substantial values. The DLA is planning Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to continue serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FFAFK?
SPE2DB25FFAFK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FFAFK worth?
The government has obligated $38,107 on SPE2DB25FFAFK.
Is contract SPE2DB25FFAFK an order under another contract?
Yes. SPE2DB25FFAFK is a delivery order under SPE2DB24D1021, an indefinite delivery contract.
Was contract SPE2DB25FFAFK competed?
The extent of competition for SPE2DB25FFAFK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award